The Knowledge Capital Fund specialized in investments in biotech companies , joins the company BIODAN Sciences with an investment of 240,000 €. This investment provides IUCT Empren a equity participation of 19% in Biodan, being able to reach up to 21'5 % in two years.
BIODAN Sciences Ltd., founded by Alfredo Brisac in 2011 , is a company dedicated to the development and manufacturing of organic and innovative active ingredients for the cosmetic and the para-pharmacy sectors, and also to the development of cosmetics with the same concept . The company bases its strategy on the development of ecological systems that release active molecules based on the most advanced developments in the field of immunology and organic nano-encapsulation. This is a revolution in natural cosmetics as it allows cosmetic ingredients penetrate the stratum corneum, which most natural ingredients today are unable to do so.
The Fund, established in late 2011 by the company IUCT Emprèn, specializes in investments in biotechnology companies in early stages of growth. Investments are not based solely on financial contributions, but seek investments that can generate synergies with other companies of the group and in turn are able to provide tecnological added value to the investment done.
The investment in BIODAN Sciences is the third conducted by the Knowledge Capital Fund (after that of Phyture Biotech and Enemce Pharma) and is intended for the creation of a new range of innovative and natural products for the cosmetics sector mainly.
BIODAN Sciences, SL
Established in 2011 aims to provide the most advanced natural ingredients , through more effective delivery mechanisms than those provided by the ingredients based on a more traditional chemical technology .
BIODAN applies the latest advances in the field of immunology and biotechnology for active ingredients extracted from plants with ancient tradition .
Foundational values for the generation of these innovative products are the use of the most advanced technologies, the quest for greater efficiency , the use of natural, safe and ethically produced and developed.
Mollet del Vallès, December 1st, 2012.
During the month of November, the Knowledge Capital Fund has made its second investment in the company Enemce Pharma with an initial contribution of € 5,500.
This contribution aims at developing a first proof of concept phase, which if successful will result in the development phase and subsequent investments.
Enemce Pharma is a classic drug discovery company created to develop a new drug candidate for the prevention of cardiovascular events.
Mollet, September 21, 2012.
Today is presented in the fair / congress BioSpain 2012 the first investment of the Knowledge Capital Fund, an investment tool to support the growth of biotechnology companies. InKemia enters into Phyture Biotech with a capital investment of € 270,000l, completing a larger funding round.
Phyture Biotech is specialized in research, development, manufacture and marketing of plant stem cells for cosmetic industries, dermatological and pharmaceutical founded in 2009 by two young entrepreneurs Oscar Albert and Jané Exposito. Phyture has among its customers some of the most known cosmetic and pharmaceutical companies. Its revenues exceded € 170,000 in 2011, and the company has been valued at about 1.2 M €
The KC Fund, created in late 2011 by the IUCT Emprèn, specializes in investments in biotechnology, pharmaceutical and chemical in early stages of growth. Investments are not based solely on financial contributions, but make investments capable of generating synergies with other companies of the group and in turn be able to offer added value technology.
The investment in Phyture Biotech is the first conducted by the Knowledge Capital Fund, and is addressed to the creation of a portfolio of high-end cosmetic applications.
Currently the fund is considering other operations, and is expected to close the next investments before year end. The Knowledge Capital Fund seeks an annual investment of about 400 000 € to cover the 4 million expected in 10 years.
About InKemia IUCT Group, s.a.
InKemia IUCT group is a business group of high-tech SMEs founded in 1997 and aims to develop new products, processes and technologies to companies in the biotechnology, pharmaceutical and chemical industries. Whose core business is based on knowledge exploitation through licensing of patents and know-how as well as R & D, and other technology services. The main areas of specialization are innovations in the fields of drug discovery and development, industrial biotechnology and green chemistry.
About Knowledge Capital Fund
IUCT Empren was created in 2010 with the mission of managing minority stakes in other companies forming the "Entrepreneurship Division". IUCT Empren manages the trading and industrial companies of the group where the holding has a participation.
The entry of IUCT Empren in the companies can be addressed throughthe Knowledge Capital Fund dependening on the business in question. The types of investment of IUCT Empren are:
- Constitution of Spin-offs created to accelerate the process of industrial and commercial exploitation of some of the group's own discoveries. Carried out in collaboration with experts in management and / or industrialization that take charge of business development of these new companies.
- Participation in the creation and growth of business initiatives developed by entrepreneurs outside the group. Through a collaboration using both technological capabilities, seeking synergies between the parties to develop an innovative business project. Through the Knowledge Capital Fund.
- Creation of joint ventures with companies technologically complementaris, developing new business opportunities through synergies.
About Phyture Biotech, SL
Created in 2009 as a spin-off of the Faculty of Pharmacy, University of Barcelona, Biotech Phyture activities are based on its technology platform for plant stem cells. With this technology you can modify the metabolism of cells to reach innovative extracts, high value-added and more effective and safer than traditional ones. Phyture Biotech is a pioneer in the application of this technology in the industry.
On the one hand, is developing a range of products based on the cultivation of singular plant cells. These products will become active ingredients for the cosmetic, pharmaceutical and dernatology industries.
In addition, research is underway to optimize the technology in production of recombinant proteins. Although currently not widely used, plant cells have great potential for the future in this sector because of their unique features.
Companies associated with PCM (PCM) have preferential access to the newly created seed capital fund of the Institut Universitari de Ciència i Tecnología (IUCT Empren) aimed at innovative technology companies. Thanks to the agreement signed by both entities, companies associated with the PCM can accessthis fund that aims to provide entrepreneurs of knowledge assets, expertise and services that has the IUCT, worth four million euros. "We want to create a new model of entrepreneurship based oninter-cooperation and exploitation of synergies arising from the resources and scientific and technological capabilities of our company," says Josep Castells, director of IUCTEmpren. Investments will be made in projects in areas such as industrial biotechnology, green chemistry, biomedical, pharmaceutical, cosmetic, functional food, fine chemicals, biofuels, among others. This agreement is part of the PCM's commitment to the promotion of a national marketbased on R & D + i for what is essential to achieve investment partners to supporttechnology-based companiessuch as those associated with the park.
Companies associated with PCM (PCM) have preferential access to the newly created seed capital fund of the Institut Universitari de Ciència i Tecnología (IUCT Empren) aimed at innovative technology companies.
Thanks to the agreement signed by both entities, companies associated with the PCM can accessthis fund that aims to provide entrepreneurs of knowledge assets, expertise and services that has the IUCT, worth four million euros. "We want to create a new model of entrepreneurship based oninter-cooperation and exploitation of synergies arising from the resources and scientific and technological capabilities of our company," says Josep Castells, director of IUCTEmpren.
Investments will be made in projects in areas such as industrial biotechnology, green chemistry, biomedical, pharmaceutical, cosmetic, functional food, fine chemicals, biofuels, among others.
This agreement is part of the PCM's commitment to the promotion of a national marketbased on R & D + i for what is essential to achieve investment partners to supporttechnology-based companiessuch as those associated with the park.
On September the 14th. at 9h 30' a.m the Knowledge Capital Fund will be presented in Madrid. This presentation will take place in the opening session of the 9th Green Chemestry Conferenced at the Colegio de San Ildefonso de la Universidad de Alcalá .
The opening ceremony of the conference will be attended to:
Dña. Elisa Robles Fraga, Directora General de Economía, Estadística e Innovación Tecnológica, Comunidad de Madrid.
Dña Regina Revilla, Presidenta Asociación Española de Empresas de Biotecnología ASEBIO.
With the presence of Honorable Sr. Andreu Mas-Colell, Conseller d'Economia i Coneixement, the Knowledge Capital Fund was presented at the IUCT headquarters of Mollet
The event also involved:
- Mr. Josep Castells, CEO of IUCT, who made the presentation and description of the Fund
- Mr. Xavier López, director general d'Economia Social i Cooperativa i Treball Autònom del Departament d’Empresa i Ocupació, that as a former president of the Clade Group will saw the born of IUCT and made a defense of the values of entrepreneurship and continuous innovation that have guided IUCT since its inception, that have led it to the pointof getting the maximum expression of these values, encouraging and assisting the creation of new enterpreneuring innovation through the Fund.
- Il•lm. Sr. Josep Monràs, alcalde de Mollet del Vallès, who defended the pride of the town to have an innovative institution as IUCT
- Honorable Sr. Andreu Mas-Colell, Conseller d'Economia i Coneixement, highlighting an instrument like the presented to support companies in their early stages, as there is still funds available for investment in higher amounts of capital risk, for this segment of Seed Capital is much harder to find financing.
The ceremony was followed by over a hundred listeners who shared a few words after the act with the Minister and IUCT representatives